Study reveals key role of glutamate tRNA fragments in brain aging and Alzheimer's disease
最近審查：14.06.2024
所有iLive內容都經過醫學審查或事實檢查，以確保盡可能多的事實準確性。
我們有嚴格的採購指南，只鏈接到信譽良好的媒體網站，學術研究機構，並儘可能與醫學同行評審的研究相關聯。 請注意括號中的數字（[1]，[2]等）是這些研究的可點擊鏈接。
如果您認為我們的任何內容不准確，已過時或有疑問，請選擇它並按Ctrl + Enter。
A research article published in the journal of Cell Metabolism by Professor Liu Qiang's team from the University of Science and Technology of China (USTC) reveals the critical role of glutamate tRNA fragments in brain aging and Alzheimer's disease.
The study revealed age-related accumulation of Glu-5'tsRNA-CTC, a small transfer RNA (tsRNA)-derived RNA that is generated from the nuclear-encoded tRNAGlu in the mitochondria of glutaminergic neurons. This abnormal accumulation disrupts mitochondrial protein translation and cristae structure, which ultimately accelerates the pathological processes of brain aging and Alzheimer's disease.
Brain aging is an inevitable natural process that leads to a decline in cognitive function. Alzheimer's disease, a neurodegenerative condition, is the most common cause of dementia in older adults, in which cognitive impairment is a prominent feature. Mitochondria provide cells with energy. Research has shown that mitochondrial dysfunction is closely linked to brain aging and Alzheimer's disease.
Mitochondrial Glu-5'tsRNA-CTC disrupts the binding of mt-tRNALeu and leucyl-tRNA synthetase 2 (LARS2), impairing mt-tRNALeu aminoacylation and translation of mitochondrial-encoded proteins. Defects in mitochondrial translation disrupt cristae architecture, leading to impaired glutaminase (GLS)-dependent glutamine production and decreased synaptic glutamate levels. In addition, reducing Glu-5'tsRNA-CTC levels may protect the aging brain from age-related defects in mitochondrial cristae, glutamine metabolism, synapse structure, and memory.
Schematic representation of the regulatory mechanisms of tRNA fragments in brain aging and Alzheimer's disease. LIU Qiang et al.
Liu and his team have shed light on the important role of glutamate tRNA fragments in brain aging and Alzheimer's disease, suggesting new approaches to slow cognitive decline. The researchers developed antisense oligonucleotides that targeted these tRNA fragments and injected them into the brains of old mice. This intervention significantly alleviated learning and memory problems in aged mice.
In addition to elucidating the physiological role of normal mitochondrial cristae ultrastructure in maintaining glutamate levels, this study also identified the pathological role of transfer RNAs in brain aging and age-related memory decline.